August 23, 2016
Exceptional growth in revenue and earnings in 2016. Increasing focus on nutritional products
NZX/ASX Market release
Highlights of financial results for the year ended 30 June 2016 (in NZ$)
- Total revenue of $352.8 million – an increase of 127.4% over the prior corresponding period (pcp)
- Net profit after tax of $30.4 million, compared with a net loss after tax of $2.1 million in the pcp
- Group Operating EBITDA[1] of $54.6 million, up from $4.8 million[2] on the pcp
- Group Operating EBITDA as a percentage of sales, before investment in international growth, of 22.4%
- Exceptional growth in sales of a2 Platinum® infant formula in Australia & New Zealand (ANZ) and China, with total revenue of $214.4 million, up 414% on pcp
- Continued growth of fresh milk in Australia, with total revenue up 4%
- An improved financial performance in the United Kingdom, and further progress in repositioning the Company as a specialty milk supplier
- Investment to support the a2 Milk™ launch programme in the United States
To view the full year results commentary 2016, please click here
To view the FY16 results presentation, please click here
To view the NZX results 2016, please click here
To view the ASX Appendix 4E 2016, please click here
To view the preliminary release 2016, please click here
